| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |